Loading…
Loading…
Bristol-Myers Squibb Company
NYSE · Stock Profile · Market Cap $120.86B
Current Price
$59.37
-0.57%GoodMoat Value
$127.94
115.5% undervaluedNet income compounded at 27.0% annually over 6 years.
Forward estimates use 35.6% FCF growth (CAGR)
Net Debt: 34.9B
12.2B
FY24
11.9B
FY24
48.3B
FY24
11.2B
FY25
12.3B
FY25
12.2B
FY25
48.2B
FY25
1.7B
FY24
1.2B
FY24
—
FY24
2.5B
FY25
1.3B
FY25
2.2B
FY25
7.1B
FY25
A healthier world is attainable and achievable, but access to healthcare remains unequal. The Bristol Myers Squibb Foundation (BMS Foundation), an independent charitable organization, is dedicated to improving global health, striving to bridge divides by empowering local communities and health systems to create lasting impact. With a vision to help create a world where everyone has the opportunity to achieve their optimal health, the BMS Foundation works to increase access to healthcare and develop grantee relationships in geographies where they are focused, including in Brazil, India, ten countries in Sub-Saharan Africa, and across the United States.
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NYSE
Country
New York, USA
Net income compounded at 27.0% annually over 6 years.
Blended fair value estimate based on DCF, Graham Number, and earnings-based models.
Run a full DCF analysis with customizable assumptions
Open DCF Calculator →Graham Number, PEG-based, and Earnings-based models
View Fair Value →Dividend Yield
4.17%
A healthier world is attainable and achievable, but access to healthcare remains unequal. The Bristol Myers Squibb Foundation (BMS Foundation), an independent charitable organization, is dedicated to improving global health, striving to bridge divides by empowering local communities and health systems to create lasting impact. With a vision to help create a world where everyone has the opportunity to achieve their optimal health, the BMS Foundation works to increase access to healthcare and develop grantee relationships in geographies where they are focused, including in Brazil, India, ten countries in Sub-Saharan Africa, and across the United States.
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NYSE
Country
New York, USA